Share ownership Recordati

REC

IT0003828271

Pharmaceuticals

Real-time Borsa Italiana Other stock markets 08:43:16 2025-01-20 am EST			5-day change	1st Jan Change
54.90 ^EUR	0.00%		+4.37%	+8.50%

Jan. 17	Recordati and its top investor say no plans for deal with Angelini	RE
Jan. 17	Recordati-Angelini, on the plan interest of sovereign wealth funds	AN

Major shareholders: Recordati

Name	Equities	%	Valuation
CVC Advisers Ltd. 51.82 %	108,368,721	51.82 %	5 692 M €
Fidelity Management & Research Co. LLC 3.527 %	7,375,844	3.527 %	387 M €
Invesco Asset Management Ltd. 2.278 %	4,763,871	2.278 %	250 M €
Fundsmith LLP 1.435 %	3,000,492	1.435 %	158 M €
Recordati SpA 1.319 %	2,758,646	1.319 %	145 M €
Norges Bank Investment Management 1.049 %	2,192,805	1.049 %	115 M €
Financière de l'Échiquier SA 0.9967 %	2,084,451	0.9967 %	109 M €
Invesco Advisers, Inc. 0.5980 %	1,250,568	0.5980 %	66 M €
Amundi Asset Management SA (Investment Management) 0.3242 %	678,037	0.3242 %	36 M €
Didner & Gerge Fonder AB 0.1952 %	408,200	0.1952 %	21 M €
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	65.16%
Recordati SpA	1.32%
Unknown	33.52%

Based on 1000 largest holdings

Geographical origin of shareholders

United Kingdom	55.91%
United States	4.38%
Italy	2.13%
France	1.65%
Norway	1.12%
Sweden	0.31%
Ireland	0.24%
Canada	0.20%
Germany	0.14%
Belgium	0.08%
Denmark	0.06%
Finland	0.05%
Australia	0.04%
Luxembourg	0.04%
Austria	0.04%
Barbados	0.03%
Switzerland	0.03%
Liechtenstein	0.01%
Japan	0.01%
Spain	0.01%

Based on 1000 largest holdings

Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical and OTC products (65.7%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.; - medicines for rare diseases (34.3%). Net sales are distributed geographically as follows: Italy (15.2%), Europe (56.4%), America (19%), Asia and Oceania (6.7%) and Africa (2.7%).

Employees

4,455

Sector

Pharmaceuticals

Calendar

2025-02-19 - Q4 2024 Earnings Release (Projected)

More about the company